Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Letter: should immunosuppressi...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply.
Bibliographic Details
Main Authors:
Reenaers, C
,
Louis, E
,
Belaiche, J
,
Seidel, L
,
Keshav, S
,
Travis, S
Format:
Journal article
Language:
English
Published:
2013
Holdings
Description
Similar Items
Staff View
Similar Items
Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?
by: Reenaers, C, et al.
Published: (2012)
Adalimumab induction therapy achieves clinical remission and response in Chinese patients with Crohn's disease
by: Wu, K, et al.
Published: (2015)
Immunosuppression for management of Crohn's disease
by: Milosevic, I, et al.
Published: (2016)
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
by: Wu, K, et al.
Published: (2016)
Editorial: gut selective immunosuppression-is it a double edged sword? Authors' reply.
by: Bye, W, et al.
Published: (2017)